Corrigendum to ’Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer’ [Cancer Research and Treatment Communications 46 (2026) 101112]
Cancer Treatment and Research Communications · 2026 · 47 · 101149
DOI: 10.1016/j.ctarc.2026.101149 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Jesus Edgardo Hernandez-Hernandez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Nuevo Leon, Mexico; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologic….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Nuevo Leon, Mexico; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico.
- Subdirección de Patología, Instituto Nacional de Cancerología, Mexico City, Mexico.
- Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Departamento de Consulta Externa, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Universidad Popular Autónoma del Estado de Puebla. Instituto Nacional de Cancerología. Residente de Ortopedia del Hospital Español, Ciudad de México, Mexico.
- Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico.
Zitieren
APA
Hernandez-Hernandez, J. E., Lara-Torres, C. O., Aranda-Gutiérrez, A., Domínguez-Porras, V. A., Moreno-Moran, B., Díaz-Pérez, H., Gómez-Macías, G. S., Cabrera-Galeana, P., Villarreal-Garza, C., & Mohar, A. (2026). Corrigendum to ’Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer’ [Cancer Research and Treatment Communications 46 (2026) 101112]. Cancer Treatment and Research Communications, 47, 101149. https://doi.org/10.1016/j.ctarc.2026.101149
Vancouver
Hernandez-Hernandez JE, Lara-Torres CO, Aranda-Gutiérrez A, Domínguez-Porras VA, Moreno-Moran B, Díaz-Pérez H, et al. Corrigendum to ’Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer’ [Cancer Research and Treatment Communications 46 (2026) 101112]. Cancer Treatment and Research Communications. 2026;47:101149. doi:10.1016/j.ctarc.2026.101149
BibTeX
@article{HernandezHernandez2026,
author = {Hernandez-Hernandez, Jesus Edgardo and Lara-Torres, César Octavio and Aranda-Gutiérrez, Alejandro and Domínguez-Porras, Víctor A and Moreno-Moran, Bryan and Díaz-Pérez, Héctor and Gómez-Macías, Gabriela Sofía and Cabrera-Galeana, Paula and Villarreal-Garza, Cynthia and Mohar, Alejandro},
title = {Corrigendum to ’Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer’ [Cancer Research and Treatment Communications 46 (2026) 101112]},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {47},
pages = {101149},
doi = {10.1016/j.ctarc.2026.101149}
}
EUVIMED